多种来源的外基因组 糖尿病伤口愈合的治疗策略
Fengyu Wang1,2, Jinling Yao3, Huiling Zuo1,2
1The Key Laboratory of Microcosmic Syndrome Differentiation, Yunnan University of Chinese Medicine, Kunming, Yunnan, 650500, People's Republic of China.
International journal of nanomedicine
|June 18, 2025
概括
外体提供有希望的再生医学策略,通过减少炎症和促进细胞生长来治疗糖尿病伤口. 本综述探讨了各种外体源,以指导个性化治疗方法.
科学领域:
- 再生医学是一种再生医学.
- 生物技术是生物技术.
- 伤口愈合 治愈 伤口愈合
背景情况:
- 由于糖尿病患者的愈合过程受损,糖尿病伤口带来了重大的临床挑战.
- 并发症包括血糖控制不良,微循环问题,细胞功能受损,增加皮肤损伤风险.
- 基于外体的疗法正在成为治疗糖尿病伤口的新策略.
研究的目的:
- 审查来自不同来源的外体的作用机制,以加速糖尿病伤口愈合.
- 为了比较哺乳动物细胞衍生的外体和植物衍生的外体样纳米颗粒的疗效.
- 为选择最佳的外体源提供一个理论框架,用于个性化糖尿病伤口治疗.
主要方法:
- 文献综述专注于基于外体的再生医学,用于糖尿病伤口愈合.
- 来自不同来源 (哺乳动物细胞,植物) 的外体组合和功能分析.
- 检查糖尿病伤口模型中对炎症,细胞迁移和血管生成的外体介导作用.
主要成果:
- 外体内含有生物活性分子 (蛋白质,脂质,RNA) 调节关键的治疗途径.
- 不同的外体源表现出不同的治疗特征和机制.
- 外体细胞有效抑制炎症,增强细胞迁移,并促进新的血管形成 (血管生成).
结论:
- 外体代表了糖尿病伤口管理的可行治疗途径.
- 外体的源依赖性特征对于治疗疗效至关重要.
- 这一评论支持开发个性化,多式外体治疗方法,用于糖尿病伤口愈合.
更多相关视频
09:17Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
437
07:03Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
2.2K
相关概念视频
Clinical Applications of Epidermal Stem Cells
2.8K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K
Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
